To see the other types of publications on this topic, follow the link: Type 2 myocardial infarction.

Journal articles on the topic 'Type 2 myocardial infarction'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Type 2 myocardial infarction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Smer, Aiman, Ray W. Squires, Ahmed Aboeata, et al. "Type 2 Myocardial Infarction." Journal of Cardiopulmonary Rehabilitation and Prevention 41, no. 3 (2021): 147–52. http://dx.doi.org/10.1097/hcr.0000000000000550.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Radovanovic, Dragana, Thomas Pilgrim, Burkhardt Seifert, Philip Urban, Giovanni Pedrazzini, and Paul Erne. "Type 2 myocardial infarction." Journal of Cardiovascular Medicine 18, no. 5 (2017): 341–47. http://dx.doi.org/10.2459/jcm.0000000000000504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dahhan, Ali. "Type 2 myocardial infarction." Journal of Cardiovascular Medicine 20, no. 8 (2019): 510–17. http://dx.doi.org/10.2459/jcm.0000000000000813.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nestelberger, Thomas, Jasper Boeddinghaus, and Christian Mueller. "Type 2 myocardial infarction." European Heart Journal 39, no. 42 (2018): 3825. http://dx.doi.org/10.1093/eurheartj/ehy535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Collinson, P. O. "Type 2 myocardial infarction." Heart 101, no. 2 (2014): 89–90. http://dx.doi.org/10.1136/heartjnl-2014-306865.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sandoval, Yader, and Allan S. Jaffe. "Type 2 Myocardial Infarction." Journal of the American College of Cardiology 73, no. 14 (2019): 1846–60. http://dx.doi.org/10.1016/j.jacc.2019.02.018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sandoval, Yader, and Allan S. Jaffe. "Type 2 Myocardial Infarction." Journal of the American College of Cardiology 81, no. 2 (2023): 169–71. http://dx.doi.org/10.1016/j.jacc.2022.11.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Strömbäck, Ulrica, Åsa Engström, Robert Lundqvist, Dan Lundblad, and Irene Vikman. "The second myocardial infarction: Is there any difference in symptoms and prehospital delay compared to the first myocardial infarction?" European Journal of Cardiovascular Nursing 17, no. 7 (2018): 652–59. http://dx.doi.org/10.1177/1474515118777391.

Full text
Abstract:
Background: Knowledge is limited concerning the type of symptoms and the time from onset of symptoms to first medical contact at first and second myocardial infarction in the same patient. Aim: This study aimed to describe the type of symptoms and the time from onset of symptoms to first medical contact in first and second myocardial infarctions in men and women affected by two myocardial infarctions. Furthermore, the aim was to identify factors associated with prehospital delays ≥2 h at second myocardial infarction. Methods: A retrospective cohort study with 820 patients aged 31–74 years with
APA, Harvard, Vancouver, ISO, and other styles
9

London, Martin J. "Type 2 Perioperative Myocardial Infarction." Anesthesiology 128, no. 6 (2018): 1055–59. http://dx.doi.org/10.1097/aln.0000000000002153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sandoval, Yader, and Kristian Thygesen. "Myocardial Infarction Type 2 and Myocardial Injury." Clinical Chemistry 63, no. 1 (2017): 101–7. http://dx.doi.org/10.1373/clinchem.2016.255521.

Full text
Abstract:
Abstract BACKGROUND The development and implementation of sensitive and high-sensitivity cardiac troponin assays has not only expedited the early ruling in and ruling out of acute myocardial infarction, but has also contributed to the identification of patients at risk for myocardial injury with necrosis, as confirmed by the presence of cardiac troponin concentrations above the 99th percentile. Myocardial injury with necrosis may occur either in the presence of overt ischemia from myocardial infarction, or in the absence of overt ischemia from myocardial injury accompanying other conditions. M
APA, Harvard, Vancouver, ISO, and other styles
11

Dahhan, Ali. "Type 2 Myocardial Infarction and Injury." Journal of the American College of Cardiology 76, no. 3 (2020): 353–54. http://dx.doi.org/10.1016/j.jacc.2020.03.088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Sandoval, Yader, Stephen W. Smith, Sarah E. Thordsen, and Fred S. Apple. "Supply/Demand Type 2 Myocardial Infarction." Journal of the American College of Cardiology 63, no. 20 (2014): 2079–87. http://dx.doi.org/10.1016/j.jacc.2014.02.541.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Landes, Uri, Tamir Bental, Katia Orvin, et al. "Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction." Journal of Cardiology 67, no. 1 (2016): 51–56. http://dx.doi.org/10.1016/j.jjcc.2015.04.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Hawatmeh, Amer, Mohammad Thawabi, Gautam Visveswaran, and Marc Cohen. "TREATMENT AND OUTCOMES OF TYPE 2 MYOCARDIAL INFARCTION COMPARED WITH TYPE 1 MYOCARDIAL INFARCTION." Journal of the American College of Cardiology 73, no. 9 (2019): 161. http://dx.doi.org/10.1016/s0735-1097(19)30769-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Motova, Anna V., Victoria N. Karetnikova, and Olga L. Barbarash. "TYPE 2 MYOCARDIAL INFARCTION: A MODERN VIEW ON THE PROBLEM." Complex Issues of Cardiovascular Diseases 12, no. 3 (2023): 192–99. http://dx.doi.org/10.17802/2306-1278-2023-12-3-192-199.

Full text
Abstract:
HighlightsThe article describes the main differences between the types of myocardial infarction, in particular, differences between type 1 and type 2 myocardial infarction, the complexity of diagnosis and management of patients with myocardial infarction type 2, and summarizes data on the prevalence of patients with myocardial infarction type 2. The arguments supporting the need for further researches to differentiate various phenotypes of myocardial infarction are provided. AbstractDespite the high interest in the study of type 2 MI, many unresolved issues concerning diagnosis, criteria for d
APA, Harvard, Vancouver, ISO, and other styles
16

Kurhaluk, Natalia, Krzysztof Tota, Małgorzata Dubik-Tota, and Halyna Tkachenko. "LIPID PEROXIDATION IN THE BLOOD OF MALES AND FEMALES WITH MYOCARDIAL INFARCTION AND DIABETES MELLITUS TYPE 2." Biota. Human. Technology, no. 2 (December 29, 2022): 67–78. http://dx.doi.org/10.58407/bht.2.22.5.

Full text
Abstract:
Individuals with diabetes have a four-fold risk of developing coronary heart disease than those without diabetes. Dyslipidemia and hypertension associated with diabetes are additional risk factors for heart attack and myocardial infarctions. Oxidative stress induces many chronic diseases, especially diabetes and heart disease. Purpose: determination of lipid peroxidation markers in males and females with type 2 diabetes, individuals who have had myocardial infarctions, and individuals with type 2 diabetes and myocardial infarctions compared with healthy individuals. Methodology. The criteria f
APA, Harvard, Vancouver, ISO, and other styles
17

Sabatine, Marc S. "Differentiating Type 1 and Type 2 Myocardial Infarction." JAMA Cardiology 6, no. 7 (2021): 781. http://dx.doi.org/10.1001/jamacardio.2021.0693.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Saaby, Lotte, Tina Svenstrup Poulsen, Susanne Hosbond, et al. "Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction." American Journal of Medicine 126, no. 9 (2013): 789–97. http://dx.doi.org/10.1016/j.amjmed.2013.02.029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Smilowitz, Nathaniel R., Pritha Subramanyam, Eugenia Gianos, Harmony R. Reynolds, Binita Shah, and Steven P. Sedlis. "Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction." Coronary Artery Disease 29, no. 1 (2018): 46–52. http://dx.doi.org/10.1097/mca.0000000000000545.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Zhelnov, V. V., N. V. Dyatlov, and L. I. Dvoretsky. "MYOCARDIAL INFARCTION TYPE 2. MYTH OR REALITY?" Archive of internal medicine 6, no. 2 (2016): 34–41. http://dx.doi.org/10.20514/2226-6704-2016-6-2-34-41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

McCarthy, Cian P., James L. Januzzi Jr, and Hanna K. Gaggin. "Type 2 Myocardial Infarction ― An Evolving Entity ―." Circulation Journal 82, no. 2 (2018): 309–15. http://dx.doi.org/10.1253/circj.cj-17-1399.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Baron, Tomasz, Kristina Hambraeus, Johan Sundström, David Erlinge, Tomas Jernberg, and Bertil Lindahl. "Type 2 myocardial infarction in clinical practice." Heart 101, no. 2 (2014): 101–6. http://dx.doi.org/10.1136/heartjnl-2014-306093.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Famularo, Giuseppe. "Status epilepticus and type 2 myocardial infarction." American Journal of Emergency Medicine 34, no. 8 (2016): 1735.e3–1735.e4. http://dx.doi.org/10.1016/j.ajem.2015.12.057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

McCarthy, Cian P., Sean Murphy, Joshua A. Cohen, et al. "CARDIAC REHABILITATION FOR TYPE 2 MYOCARDIAL INFARCTION." Journal of the American College of Cardiology 73, no. 9 (2019): 165. http://dx.doi.org/10.1016/s0735-1097(19)30773-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Sandoval, Yader, Stephen W. Smith, and Fred S. Apple. "Ongoing Challenges with Type 2 Myocardial Infarction." American Journal of Medicine 129, no. 8 (2016): e155. http://dx.doi.org/10.1016/j.amjmed.2016.01.031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Alpert, Joseph S. "Further Insights into Type 2 Myocardial Infarction." American Journal of Medicine 133, no. 10 (2020): 1116–17. http://dx.doi.org/10.1016/j.amjmed.2020.05.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Sandoval, Yader, Stephen W. Smith, and Fred S. Apple. "Type 2 Myocardial Infarction: The Next Frontier." American Journal of Medicine 127, no. 6 (2014): e19. http://dx.doi.org/10.1016/j.amjmed.2014.02.027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

BARBARASH, OLGA L., and VASILIY V. KASHTALAP. "FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION." Fundamental and Clinical Medicine 3, no. 4 (2018): 73–82. http://dx.doi.org/10.23946/2500-0764-2018-3-4-73-82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Soylu, Ahmet, Kurtulus Ozdemir, Mehmet Akif Duzenli, Mehmet Yazici, and Mehmet Tokac. "Impact on Diabetes Mellitus on the Epicardial Coronary Flow Velocity Assessed by the Thrombolysis in Myocardial Infarction Frame Count." Angiology 60, no. 4 (2008): 431–40. http://dx.doi.org/10.1177/0003319708321187.

Full text
Abstract:
The aim of this study is to evaluate the effect of type 2 diabetes mellitus on epicardial coronary flow velocity assessed by the thrombolysis in myocardial infarction frame count. The thrombolysis in myocardial infarction frame count was measured in 272 coronary arteries from 101 patients with type 2 diabetes mellitus and in 271 coronary arteries from 104 age- and gender-matched patients without type 2 diabetes mellitus referred for coronary angiography. The thrombolysis in myocardial infarction frame count was measured only in normal arteries or in arteries without significant lesion. By both
APA, Harvard, Vancouver, ISO, and other styles
30

Saaby, L., T. S. Poulsen, S. Hosbond, et al. "Mortality in type 1 vs. type 2 myocardial infarction." European Heart Journal 34, suppl 1 (2013): P1331. http://dx.doi.org/10.1093/eurheartj/eht308.p1331.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Helwani, Mohammad A., Amit Amin, Paul Lavigne, et al. "Etiology of Acute Coronary Syndrome after Noncardiac Surgery." Anesthesiology 128, no. 6 (2018): 1084–91. http://dx.doi.org/10.1097/aln.0000000000002107.

Full text
Abstract:
Abstract Background The objective of this investigation was to determine the etiology of perioperative acute coronary syndrome with a particular emphasis on thrombosis versus demand ischemia. Methods In this retrospective cohort study, adult patients were identified who underwent coronary angiography for acute coronary syndrome within 30 days of noncardiac surgery at a major tertiary hospital between January 2008 and July 2015. Angiograms were independently reviewed by two interventional cardiologists who were blinded to clinical data and outcomes. Acute coronary syndrome was classified as ST–
APA, Harvard, Vancouver, ISO, and other styles
32

Dervisevic, Emina, Anes Jogunčić, Muamer Dervišević, et al. "Increased mean platelet volume is associated with acute myocardial infarction in patients with diabetes mellitus type 2." International Journal of Research in Medical Sciences 10, no. 7 (2022): 1426. http://dx.doi.org/10.18203/2320-6012.ijrms20221784.

Full text
Abstract:
Background: The correlation between diabetes mellitus and acute myocardial infarction is greater every day. The mean platelet volume (MPV), which is the determinant of platelet function, is an independent risk factor for the cardiovascular disease. The aim of the study was to investigate the effect of each disease (hypothyroidism, hypertension, myocardial infarction) individually and combined on MPV in diabetic patients.Methods: The cross-sectional study included 102 patients who suffer from diabetes mellitus type 2 (DMT2), of both sexes (46 females, 56 males), with the average age of 58.91 (S
APA, Harvard, Vancouver, ISO, and other styles
33

Marshell, Ramey, Chad Colon, Christopher Roth, Ayman Farag, Ami Iskandrian, and Fadi Hage. "TYPE 2 MYOCARDIAL INFARCTION RISK STRATIFICATION VIA MYOCARDIAL PERFUSION IMAGING." Journal of the American College of Cardiology 73, no. 9 (2019): 1656. http://dx.doi.org/10.1016/s0735-1097(19)32262-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Feldman, D. А., N. G. Ryndina, P. G. Kravchun, I. G. Krayz, and V. F. Zabashta. "Prognostic Value of Asymmetric Dimethylarginine in the Development of Complications in the Hospital Period of Acute Myocardial Infarction with ST-Segment Elevation in Patients with Type 2 Diabetes Mellitus." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, no. 1 (2021): 145–52. http://dx.doi.org/10.26693/jmbs06.01.145.

Full text
Abstract:
The purpose of the study was to determine the prognostic value of asymmetric dimethylarginine in the development of complications in the hospital period of acute myocardial infarction with ST segment elevation in patients with type 2 diabetes mellitus. Material and methods. The study design consisted of 120 patients. They were divided into 2 groups. Group 1 consisted of patients with acute myocardial infarction and concomitant type 2 diabetes mellitus (n=70), group 2 included patients with acute myocardial infarction without concomitant type 2 diabetes mellitus (n=50). Patients of both groups
APA, Harvard, Vancouver, ISO, and other styles
35

Kinash, V. I., A. S. Vorobev, I. A. Urvantseva, L. V. Kovalenko, and V. V. Kashtalap. "Controversial issues of type 2 myocardial infarction patients management." Complex Issues of Cardiovascular Diseases 11, no. 1 (2022): 78–89. http://dx.doi.org/10.17802/2306-1278-2022-11-1-78-89.

Full text
Abstract:
Highlights. The article presents relevant literary data on the epidemiology, main causes, approaches to the diagnostics and treatment of type 2 myocardial infarction patients. The authors emphasize an unfavorable prognosis in these patients due to comorbidity that leads to development of myocardial infarction. They highlight the need to improve and unify approaches to identifying this phenomenon, as well as the necessity to conduct observational and randomized studies to evaluate approaches to the treatment of type 2 myocardial infarction patients.Abstract. The article summarizes the available
APA, Harvard, Vancouver, ISO, and other styles
36

Petrov, S. S., V. A. Shulman, and T. D. Vereschagina. "A rare case of type 2 myocardial infarction development in a patient with Wolf-Parkinson-White syndrome." Siberian Medical Review, no. 1 (2021): 111–14. http://dx.doi.org/10.20333/2500136-2021-1-111-114.

Full text
Abstract:
Currently, myocardial infarction diagnostics has no diffi culties. Type 2 myocardial infarction is an exception, as it occurs due to a mismatch with oxygen delivery along coronary arteries and myocardial demand for it. Th e disease is secondary and this is the main diffi culty for its diagnostics. The article described a case of a young man having Wolff -Parkinson-White syndrome with type 2 myocardial infarction development. The main cause of myocardial necrosis is a prolonged paroxysm of reciprocal atrioventricular antidromic tachycardia.
APA, Harvard, Vancouver, ISO, and other styles
37

Feldman, D. A. "Dynamics of the Level of Endothelial Monocyte Activating Polypeptide-ІI in Patients with Acute Myocardial Infarction with Concomitant Diabetes Mellitus Type 2". Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 7, № 6 (2022): 109–15. http://dx.doi.org/10.26693/jmbs07.06.109.

Full text
Abstract:
The purpose of the study was to investigate the dynamics of endothelial monocyte activating polypeptide-ІІ in patients with acute myocardial infarction with concomitant diabetes mellitus type 2 six months after a coronary event. Materials and methods. 120 patients participated in the study: group 1 – patients with acute myocardial infarction with diabetes mellitus type 2 (n=70), group 2 – patients with acute myocardial infarction (n=50). The control group included 20 practically healthy people. All patients underwent laboratory and instrumental examination on the first day of acute myocardial
APA, Harvard, Vancouver, ISO, and other styles
38

Gamayunov, D. Yu, A. N. Kalyagin, N. M. Balabina, et al. "Type 2 Myocardial Infarction on the Background of Coronary Vasospasm and Invasive Tactics of Its Diagnosis and Treatment." Russian Archives of Internal Medicine 13, no. 5 (2023): 352–59. http://dx.doi.org/10.20514/2226-6704-2023-13-5-352-359.

Full text
Abstract:
Currently, type 2 myocardial infarction is a rather significant problem, both in terms of diagnosis and treatment. Myocardial infarction without obstructive coronary artery damage occurs in 5-10 % of patients with a myocardial infarction. Optimal strategies for the diagnosis and treatment of patients with myocardial damage associated with non-thrombotic mechanisms have not yet been determined. The article describes a clinical observation of type 2 myocardial infarction on the background of vasospasm, as well as diagnostic and therapeutic tactics in this clinical situation. The main provisions:
APA, Harvard, Vancouver, ISO, and other styles
39

MUTALOVA, ELVIRA G., VELENA R. GALYAUTDINOVA, GULNARA J. KAMALTDINOVA, and LIANA I. SAMIGULLINA. "LIFE QUALITY OF MYOCARDIAL INFARCTION PATIENTS ACCORDING TO THE PRESENCE OF TYPE D PERSONALITY." Bulletin of Contemporary Clinical Medicine 17, no. 2 (2024): 64–70. http://dx.doi.org/10.20969/vskm.2024.17(2).64-70.

Full text
Abstract:
Introduction. Type D personality, or distress personality, i. e., a combination of negative affectivity and social inhibition, as well as poor life quality, are considered the predictors of cardiovascular morbidity and mortality. However, there is insufficient data on the role of Type D personality as a determinant of life quality in myocardial infarction patients. Aim is to assess the Q-positive myocardial infarction patients’ life quality and its association with Type D personality. Materials and Methods. The study included 158 patients aged 58.2±2.5 years, who were admitted to the hospital for
APA, Harvard, Vancouver, ISO, and other styles
40

Bularga, Anda, John Hung, Marwa Daghem, et al. "Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study." Circulation 145, no. 16 (2022): 1188–200. http://dx.doi.org/10.1161/circulationaha.121.058542.

Full text
Abstract:
Background: Type 2 myocardial infarction is caused by myocardial oxygen supply-demand imbalance, and its diagnosis is increasingly common with the advent of high-sensitivity cardiac troponin assays. Although this diagnosis is associated with poor outcomes, widespread uncertainty and confusion remain among clinicians as to how to investigate and manage this heterogeneous group of patients with type 2 myocardial infarction. Methods: In a prospective cohort study, 8064 consecutive patients with increased cardiac troponin concentrations were screened to identify patients with type 2 myocardial inf
APA, Harvard, Vancouver, ISO, and other styles
41

Koteliukh, M. Yu. "Relationship between Biomarkers of Carbohydrate, Energy and Adipokine Metabolism in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 7, no. 3 (2022): 147–52. http://dx.doi.org/10.26693/jmbs07.03.147.

Full text
Abstract:
The purpose of the study was to examine the indicators of carbohydrate, energy and adipokine metabolism in acute myocardial infarction patients with or without type 2 diabetes mellitus. Materials and methods. A total of 134 patients with ST-segment elevation acute myocardial infarction in the presence or absence of type 2 diabetes mellitus aged 58.97 ± 7.92 years were examined in the Government Institution “L. T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine” and Kharkiv Railway Clinical Hospital No. 1 of the “Center of Healthcare” branch of Public Jo
APA, Harvard, Vancouver, ISO, and other styles
42

Fent, Graham J., Hazlyna Kamaruddin, Pankaj Garg, Ahmed Iqbal, Nicholas F. Kelland, and Ian R. Hall. "Hypertensive Emergency and Type 2 Myocardial Infarction Resulting From Pheochromocytoma and Concurrent Capnocytophaga Canimorsus Infection." Open Cardiovascular Medicine Journal 8, no. 1 (2014): 43–47. http://dx.doi.org/10.2174/1874192401408010043.

Full text
Abstract:
A diagnosis of myocardial infarction is made using a combination of clinical presentation, electrocardiogram and cardiac biomarkers. However, myocardial infarction can be caused by factors other than coronary artery plaque rupture and thrombosis. We describe an interesting case presenting with hypertensive emergency and type 2 myocardial infarction resulting from Pheochromocytoma associated with Capnocytophaga canimorsus infection from a dog bite. We also review current literature on the management of hypertensive emergency and Pheochromocytoma.
APA, Harvard, Vancouver, ISO, and other styles
43

Zharsky, S. L. "Type 2 myocardial infarction: Solved and unsolved issues." Russian Heart Journal 15, no. 6 (2016): 404–9. http://dx.doi.org/10.18087/rhj.2016.6.2285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Coscia, Tania, Thomas Nestelberger, Jasper Boeddinghaus, et al. "Characteristics and Outcomes of Type 2 Myocardial Infarction." JAMA Cardiology 7, no. 4 (2022): 427. http://dx.doi.org/10.1001/jamacardio.2022.0043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Sateesh, K., Stitha Pragna, and Y. Raju. "Type 2 Myocardial Infarction in Acute Medical Care." Indian Journal of Cardiovascular Disease in Women WINCARS 01, no. 04 (2016): 021–24. http://dx.doi.org/10.1055/s-0038-1656498.

Full text
Abstract:
AbstractBackground: Type 2 myocardial infarction (MI) is defined as MI secondary to ischemia due to either increased oxygen demand or decreased supply. It is seen in conditions other than coronary artery disease (CAD) contributes to an imbalance between myocardial oxygen supply and/or demand. Little is known about patient characteristics and clinical outcomes.Methods: A retrospective analysis was performed in patients who were admitted in acute medical care with symptoms suggestive of myocardial ischemia and enzymatic elevation from January 2015 to December 2015. Patients with slight elevation
APA, Harvard, Vancouver, ISO, and other styles
46

Furie, Nadav, Ariel Israel, Lee Gilad, et al. "Type 2 myocardial infarction in general medical wards." Medicine 98, no. 41 (2019): e17404. http://dx.doi.org/10.1097/md.0000000000017404.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Neumann, Johannes Tobias, Nils Arne Sörensen, Nicole Rübsamen, et al. "Discrimination of patients with type 2 myocardial infarction." European Heart Journal 38, no. 47 (2017): 3514–20. http://dx.doi.org/10.1093/eurheartj/ehx457.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Collinson, Paul, and Bertil Lindahl. "Type 2 myocardial infarction: the chimaera of cardiology?" Heart 101, no. 21 (2015): 1697–703. http://dx.doi.org/10.1136/heartjnl-2014-307122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

McCarthy, Cian P., Sean Murphy, Saad Rehman, et al. "HEART FAILURE EVENTS AFTER TYPE 2 MYOCARDIAL INFARCTION." Journal of the American College of Cardiology 75, no. 11 (2020): 125. http://dx.doi.org/10.1016/s0735-1097(20)30752-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Januzzi, James L., and Yader Sandoval. "The Many Faces of Type 2 Myocardial Infarction." Journal of the American College of Cardiology 70, no. 13 (2017): 1569–72. http://dx.doi.org/10.1016/j.jacc.2017.07.784.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!